Clinical trial
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With…
NCT00031681 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00031681 |
|---|---|
| Title | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
| Official title | A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Washington University Siteman Cancer Center |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer, Extensive Stage Small Cell Lung Cancer, Gastrointestinal Stromal Tumor, HER2-negative Breast Cancer, Metastatic Gastrointestinal Carcinoid Tumor, Ovarian Sarcoma, Ovarian Stromal Cancer, Progesterone Receptor-negative Breast Cancer and 79 more |
| Intervention type | Drug, Other |
| Interventions | 7-hydroxystaurosporine, irinotecan hydrochloride, diagnostic laboratory biomarker analysis |
| Enrollment | 41 |
| Start date | Dec 1, 2001 |
| Primary completion | Jan 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: